FDA
approval
· 2023-03-09
FDA Approved: ZAVZPRET — Original Application (Pfizer Laboratories Div Pfizer Inc)
Summary
FDA approved the original application for Zavzpret (zavegepant) from Pfizer Inc. for the treatment of migraine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ZAVZPRET (ZAVEGEPANT)